ADAP
Adaptimmune Therapeutics
ADAP
ADAP
43 hedge funds and large institutions have $77.9M invested in Adaptimmune Therapeutics in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 13 closing their positions.
Holders
43
Holders Change
-6
Holders Change %
-12.24%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
12
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Wells Fargo
San Francisco,
California
| $0 | 250 | -550 | -69% |
|
|
GT
52
Glenmede Trust
Philadelphia,
Pennsylvania
| – | – | -375 | Closed |
|
53
Daiwa Securities Group
Tokyo,
Japan
| – | – | -323 | Closed |
|
54
Simplex Trading
Chicago,
Illinois
| – | – | -65 | Closed |
|
|
PA
55
Parallel Advisors
San Francisco,
California
| – | – | – | – |
|
56
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
ASN
57
Advisory Services Network
Atlanta,
Georgia
| $0 | 100 | – | – |
|
|
CFGS
58
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
AG
59
Advisor Group
Phoenix,
Arizona
| $0 | 400 | – | – |
|